These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
467 related articles for article (PubMed ID: 21763068)
1. NDRG1 as a biomarker for metastasis, recurrence and of poor prognosis in hepatocellular carcinoma. Cheng J; Xie HY; Xu X; Wu J; Wei X; Su R; Zhang W; Lv Z; Zheng S; Zhou L Cancer Lett; 2011 Nov; 310(1):35-45. PubMed ID: 21763068 [TBL] [Abstract][Full Text] [Related]
2. N-myc downstream regulated gene 1 (NDRG1)/Cap43 enhances portal vein invasion and intrahepatic metastasis in human hepatocellular carcinoma. Akiba J; Ogasawara S; Kawahara A; Nishida N; Sanada S; Moriya F; Kuwano M; Nakashima O; Yano H Oncol Rep; 2008 Dec; 20(6):1329-35. PubMed ID: 19020710 [TBL] [Abstract][Full Text] [Related]
3. Hypoxia and retinoic acid-inducible NDRG1 expression is responsible for doxorubicin and retinoic acid resistance in hepatocellular carcinoma cells. Jung EU; Yoon JH; Lee YJ; Lee JH; Kim BH; Yu SJ; Myung SJ; Kim YJ; Lee HS Cancer Lett; 2010 Dec; 298(1):9-15. PubMed ID: 20573444 [TBL] [Abstract][Full Text] [Related]
4. Importin-α1 as a novel prognostic target for hepatocellular carcinoma. Yoshitake K; Tanaka S; Mogushi K; Aihara A; Murakata A; Matsumura S; Mitsunori Y; Yasen M; Ban D; Noguchi N; Irie T; Kudo A; Nakamura N; Tanaka H; Arii S Ann Surg Oncol; 2011 Jul; 18(7):2093-103. PubMed ID: 21286940 [TBL] [Abstract][Full Text] [Related]
5. Prognostic value of NDRG1 and SPARC protein expression in breast cancer patients. Nagai MA; Gerhard R; Fregnani JH; Nonogaki S; Rierger RB; Netto MM; Soares FA Breast Cancer Res Treat; 2011 Feb; 126(1):1-14. PubMed ID: 20369286 [TBL] [Abstract][Full Text] [Related]
6. Genomic analysis reveals RhoC as a potential marker in hepatocellular carcinoma with poor prognosis. Wang W; Yang LY; Huang GW; Lu WQ; Yang ZL; Yang JQ; Liu HL Br J Cancer; 2004 Jun; 90(12):2349-55. PubMed ID: 15150600 [TBL] [Abstract][Full Text] [Related]
7. N-Myc down-regulated gene 1 mediates proliferation, invasion, and apoptosis of hepatocellular carcinoma cells. Yan X; Chua MS; Sun H; So S Cancer Lett; 2008 Apr; 262(1):133-42. PubMed ID: 18207320 [TBL] [Abstract][Full Text] [Related]
8. Clinicopathologic significance and function of S-phase kinase-associated protein 2 overexpression in hepatocellular carcinoma. Zhang SH; Qian YM; Liu AW; Cai J; Zhao XL; Wei JJ; Zhu MH Hum Pathol; 2012 Jul; 43(7):1084-93. PubMed ID: 22204716 [TBL] [Abstract][Full Text] [Related]
9. Overexpression of osteopontin is associated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular carcinoma. Pan HW; Ou YH; Peng SY; Liu SH; Lai PL; Lee PH; Sheu JC; Chen CL; Hsu HC Cancer; 2003 Jul; 98(1):119-27. PubMed ID: 12833464 [TBL] [Abstract][Full Text] [Related]
10. Stathmin1 overexpression associated with polyploidy, tumor-cell invasion, early recurrence, and poor prognosis in human hepatoma. Hsieh SY; Huang SF; Yu MC; Yeh TS; Chen TC; Lin YJ; Chang CJ; Sung CM; Lee YL; Hsu CY Mol Carcinog; 2010 May; 49(5):476-87. PubMed ID: 20232364 [TBL] [Abstract][Full Text] [Related]
11. Co-expression of XIAP and cyclin D1 complex correlates with a poor prognosis in patients with hepatocellular carcinoma. Che Y; Ye F; Xu R; Qing H; Wang X; Yin F; Cui M; Burstein D; Jiang B; Zhang DY Am J Pathol; 2012 May; 180(5):1798-807. PubMed ID: 22429965 [TBL] [Abstract][Full Text] [Related]
12. CD24 is a novel predictor for poor prognosis of hepatocellular carcinoma after surgery. Yang XR; Xu Y; Yu B; Zhou J; Li JC; Qiu SJ; Shi YH; Wang XY; Dai Z; Shi GM; Wu B; Wu LM; Yang GH; Zhang BH; Qin WX; Fan J Clin Cancer Res; 2009 Sep; 15(17):5518-27. PubMed ID: 19706825 [TBL] [Abstract][Full Text] [Related]
13. Aberrant methylation of the CADM1 promoter is associated with poor prognosis in hepatocellular carcinoma treated with liver transplantation. Zhang W; Zhou L; Ding SM; Xie HY; Xu X; Wu J; Chen QX; Zhang F; Wei BJ; Eldin AT; Zheng SS Oncol Rep; 2011 Apr; 25(4):1053-62. PubMed ID: 21271221 [TBL] [Abstract][Full Text] [Related]
14. Identification of the A kinase anchor protein 12 (AKAP12) gene as a candidate tumor suppressor of hepatocellular carcinoma. Hayashi M; Nomoto S; Kanda M; Okamura Y; Nishikawa Y; Yamada S; Fujii T; Sugimoto H; Takeda S; Kodera Y J Surg Oncol; 2012 Mar; 105(4):381-6. PubMed ID: 22052684 [TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor-containing fibulin-like extracellular matrix protein 1, EFEMP1, a novel tumor-suppressor gene detected in hepatocellular carcinoma using double combination array analysis. Nomoto S; Kanda M; Okamura Y; Nishikawa Y; Qiyong L; Fujii T; Sugimoto H; Takeda S; Nakao A Ann Surg Oncol; 2010 Mar; 17(3):923-32. PubMed ID: 19898900 [TBL] [Abstract][Full Text] [Related]
16. dUTP pyrophosphatase expression correlates with a poor prognosis in hepatocellular carcinoma. Takatori H; Yamashita T; Honda M; Nishino R; Arai K; Yamashita T; Takamura H; Ohta T; Zen Y; Kaneko S Liver Int; 2010 Mar; 30(3):438-46. PubMed ID: 19968781 [TBL] [Abstract][Full Text] [Related]
17. [The expression and significance of heparanase and nm23-H1 in hepatocellular carcinoma]. Liu Y; Chen X; Peng S; Fang H; Wu Y; Peng C; Shi L; Bai M; Xu B; Wang J; Deng G Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(22):1553-6. PubMed ID: 12609066 [TBL] [Abstract][Full Text] [Related]
18. Reduced N-cadherin expression is associated with metastatic potential and poor surgical outcomes of hepatocellular carcinoma. Zhan DQ; Wei S; Liu C; Liang BY; Ji GB; Chen XP; Xiong M; Huang ZY J Gastroenterol Hepatol; 2012 Jan; 27(1):173-80. PubMed ID: 21777276 [TBL] [Abstract][Full Text] [Related]
20. Increased expression of Wiskott-Aldrich syndrome protein family verprolin-homologous protein 2 correlated with poor prognosis of hepatocellular carcinoma. Yang LY; Tao YM; Ou DP; Wang W; Chang ZG; Wu F Clin Cancer Res; 2006 Oct; 12(19):5673-9. PubMed ID: 17020969 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]